Title: Chronic lymphocytic leukemia and Multiple myeloma.

This was a very interesting scientific event, organised by the Institute of Applied Biosciences/The Centre for Research and Technology, Hellas (INAB/CERTH) and Janssen at Thessaloniki, Greece. The venue was Hotel Nikopolis and the event took place on May 27, 2017.
The scientific program was built around recent developments regarding chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). In addition, there has been an extensive discussion regarding clinical and professional experiences among all the participants. The event ended with a talk regarding Emotional Intelligence in Clinical Communication.

Title: “Immunoglobulin Gene Analysis in CLL: from prognosis and prediction to follow-up.”
To begin with, this was a first class opportunity to return to Uppsala (thank you all for the warm welcoming). The Workshop was really interesting, organized at Uppsala, Sweden by Rudbecklaboratoriet (Uppsala University), on September 22 – 23, 2016.
 
The scientific program included five main sessions:
i) IG Sequence Analysis.
ii) Practical Exercises.
iii) IG genes for clinician decision-making.
iv) Immunogenetics in the NGS era.
v) Immunogenetics and disease follow-up: tracking MRD.
This was a high-level educational experience, and even more, a great opportunity for fruitful discussions regarding further steps. Hopefully, the fruitful discussions held during the coffee breaks of the Workshop regarding data recording in a combined multi-scheme would lead to further action, setting the cornerstone for personalized prediction applications.

Title: “Hematology Experience Exchange.“

This was an educational scientific event, organised by the Institute of Applied Biosciences/The Centre for Research and Technology, Hellas (INAB/CERTH) at Thessaloniki, Greece. The venue was INAB and the event took place on September 17, 2016.
 
The scientific program included three main sessions:
a) A holistic approach of CLL.
b) The patient’s perspective, communcation with the phycisian.
c) Workshop – Role Plays.
Overall, this was a highly interactive experience, in particular regarding chronic lymphocytic leukemia (CLL), with a vivid opportunity and encouragementfor the audience to interact with the speakers.

Title: Cancer Genomics Course.
​
This was a highly-educational scientific event. The Venue was the European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus at Hinxton (Cambridge), United Kingdom. It took place on June 27, 2016 – July 1, 2016.
 
The focus of this course was the analysis of data from genomic studies of Cancer.  The lectures were oriented towards giving an insight into the bioinformatic concepts required to analyze such data. Some practical sessions provided the participants with the opportunity to apply statistical methods to the analysis of cancer genomics data under the guidance of the lecturers and teaching assistants.
 
The Programme included sessions, among else, on:
a) Introduction to high-throughput sequencing and its application in cancer,
b) SNV analysis,
c) SV analysis,
d) CNV analysis using NGS data,
e) Methylation analysis in cancer,
f) RNA-seq analysis in cancer,
g) From genomes to networks.

Title: “Biomarkers integration in CLL patients’ management.“
​
This was a highly-educational scientific event, organised by the Institute of Applied Biosciences/The Centre for Research and Technology, Hellas (INAB/CERTH) at Thessaloniki, Greece. The venue was INAB and the event took place on June 4, 2016.
The scientific program was built around the integration of biomarkers when managing patients with chronic lymphocytic leukemia (CLL). In particular the focus was on gene TP53. The coordination of the event was towards not solely the direction of presenting results, but sharing knowledge in an interactive fashion as well. More specifically, the event included two interactive sessions where the audience had the opportunity to actively participate in the discussion. Even more, interaction among the participants was successfully encouraged throughout the event leading to a fruitful, educational and training experience.

​Title: “Tradition and innovation in the treatment of low-grade B-cell lymphomas: where to from now?”

​​This was an interesting scientific event, organised in Athens (Hotel Divani Caravel), Greece on
Saturday, April 23, 2016.
The scientific program included three main sessions:
a) Follicular lymphoma: biological revelations and therapeutic advances.
b) CLL: understanding the biology for improving outcomes.
c) Making strides against CLL: harnessing biological knowledge for treating the disease.
 
Overall, this was a high-level educational experience, in particular regarding chronic lymphocytic leukemia (CLL), with an interesting opportunity for the audience to interact with the speakers via a question & answer tool.